Medigene (MDG1.DE)

Quick facts

Marketed products

• Veregen · Other

Phase 2 pipeline

• EndoTAG-1 and Gemcitabine · Oncology
  EndoTAG-1 is a peptide that targets the tumor vasculature, while Gemcitabine is a nucleoside analog that interferes with DNA synthesis.

Phase 1 pipeline

• G207, an oncolytic virus
• NV1020

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Medigene portfolio CI brief
• Medigene pipeline updates RSS